ebomi
Colour theme
Sign in
Insider · CIK 0001251512

Flanagan Robert J

CIK 0001251512 Name as filed on the most recent filing

Filed as Flanagan Robert J (22)

33 transaction lines · from 22 filings · filed 2004-12-23 to 2020-03-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

33 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-03-03 P, Open-market purchase W. P. Carey Inc.WPC 82,290, acquired Open Form 4 filing 0001209191-20-016702
2014-10-22 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 255,920, disposed Open Form 4 filing 0001181431-14-034704
2014-10-08 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 255,680, disposed Open Form 4 filing 0001181431-14-034077
2014-10-07 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 249,200, disposed Open Form 4 filing 0001181431-14-034077
2014-09-25 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 237,760, disposed Open Form 4 filing 0001181431-14-032640
2014-09-24 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 242,400, disposed Open Form 4 filing 0001181431-14-032640
2014-09-12 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 226,000, disposed Open Form 4 filing 0001181431-14-031877
2014-09-11 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 226,800, disposed Open Form 4 filing 0001181431-14-031877
2014-08-28 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 216,560, disposed Open Form 4 filing 0001181431-14-030578
2014-08-27 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 218,400, disposed Open Form 4 filing 0001181431-14-030578
2014-08-12 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 195,120, disposed Open Form 4 filing 0001181431-14-029057
2014-08-11 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 195,120, disposed Open Form 4 filing 0001181431-14-029057
2014-07-31 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 201,600, disposed Open Form 4 filing 0001181431-14-027891
2014-07-30 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 208,000, disposed Open Form 4 filing 0001181431-14-027891
2014-07-18 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 208,880, disposed Open Form 4 filing 0001181431-14-027062
2014-07-17 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 210,000, disposed Open Form 4 filing 0001181431-14-027062
2014-07-02 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 213,600, disposed Open Form 4 filing 0001181431-14-026046
2014-07-01 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 210,480, disposed Open Form 4 filing 0001181431-14-026046
2014-06-18 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 186,080, disposed Open Form 4 filing 0001181431-14-024416
2014-06-17 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 187,760, disposed Open Form 4 filing 0001181431-14-024416
2014-06-04 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 178,320, disposed Open Form 4 filing 0001181431-14-022751
2014-06-03 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 176,400, disposed Open Form 4 filing 0001181431-14-022751
2014-05-22 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 176,160, disposed Open Form 4 filing 0001181431-14-021012
2013-09-16 S, Open-market sale Sagent Pharmaceuticals, Inc.SGNT 10,014,100, disposed Open Form 4 filing 0001209191-13-044711
2011-11-23 P, Open-market purchase Sagent Pharmaceuticals, Inc.SGNT 20,180, acquired Open Form 4 filing 0001181431-11-057581
2011-08-16 P, Open-market purchase Sagent Pharmaceuticals, Inc.SGNT 19,750, acquired Open Form 4 filing 0001181431-11-045895
2011-08-15 P, Open-market purchase Sagent Pharmaceuticals, Inc.SGNT 19,950, acquired Open Form 4 filing 0001181431-11-045895
2007-05-08 P, Open-market purchase Castle Brands IncROX 1,000,005, acquired Open Form 4 filing 0001355821-07-000021
2006-09-12 P, Open-market purchase Martek Biosciences CorpMATK 53,700, acquired Open Form 4 filing 0001209191-06-049687
2006-09-11 P, Open-market purchase Martek Biosciences CorpMATK 52,100, acquired Open Form 4 filing 0001209191-06-049577
2006-04-10 P, Open-market purchase Castle Brands IncROX 180,000, acquired Open Form 4 filing 0001355821-06-000038
2004-12-23 P, Open-market purchase Martek Biosciences CorpMATK 99,240, acquired Open Form 4 filing 0001209191-05-005974
2004-12-23 P, Open-market purchase Martek Biosciences CorpMATK 99,240, acquired Open Form 4 filing 0001209191-04-059330

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 23
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. FLANAGAN ROBERT J, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001251512

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.